Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Shows More Of An Open Door To Overseas Medtech Industry

Executive Summary

China's influence on global medtech regulation and the country's continuing emergence on the world stage will be felt increasingly in the coming years. But while China may be less inclined to exclude big medtech multinationals, it feels no compulsion to harmonize totally with the US and/or EU systems.


Related Content

US Trade Rep Details Seven Ways China Unfairly Competes With US Device Manufacturers
Industry Responds To Vietnam's Draft Decree 36, And Justifies 2020 Deadline Extension
Bigger, Bolder, SMAR: Decoding China's All-In-One Regulatory Agency
International Regulators To Make Medtech Standards More Fit For Purpose
China's Medtech Regulatory Reforms Yet To Enter Steady Path
China Hopes To Implement Unique Device Identifier System By Year End


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts